Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jianxin Qian"'
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Background Crizotinib, an oral first-generation tyrosine kinase inhibitor (TKI), is superior to systemic chemotherapy for the treatment of non-small cell lung cancer (NSCLC) with positive rearrangement of anaplastic lymphoma kinase (ALK). Ho
Externí odkaz:
https://doaj.org/article/5db92842136e49f1a1a92d4ef89b41b0
Publikováno v:
Health Science Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background and Aims The occurrence, growth, and metastasis of colorectal cancer (CRC) are connected to the hypercoagulable state of blood (CRC). This study aimed to identify significant coagulation factors to predict metastasis and prognosis
Externí odkaz:
https://doaj.org/article/977e41ee395740fc902b22b188770529
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-9 (2021)
Abstract Background Pancreatic adenocarcinoma (PAAD) is a nonimmunogenic tumor, and very little is known about the relationship between the host immune response and patient survival. We aimed to develop an immune prognostic model (IPM) and analyze it
Externí odkaz:
https://doaj.org/article/81159b8ad69f44ccbb8fab00ae78a4b5
Publikováno v:
Cell & Bioscience, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Background Ribosomal protein 34 (RPL34) is a highly conserved protein belonging to the 60S large subunit of mammalian ribosomes that has been found to be dysregulated in a variety of human tumors. However, there are limited results that illu
Externí odkaz:
https://doaj.org/article/964c82f180c441ccb3f05dd8a44d411a
Autor:
Xin Li, Jiahua Xu, Xiaoqiang Gu, Ling Chen, Qing Wu, Hongwei Li, Haoran Bai, Jinzu Yang, Jianxin Qian
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundHepatocellular carcinoma (HCC) is a common gastrointestinal malignancy with high incidence and poor prognosis. Common treatment methods include surgery, transcatheter arterial chemoembolization (TACE), ablation, and targeted therapy. In rec
Externí odkaz:
https://doaj.org/article/f5358ee7757745d0b33ebc65bfe5f07c
Autor:
Yunshu Gao, Dongyun Xu, Hongwei Li, Jiahua Xu, Yating Pan, Xinyi Liao, Jianxin Qian, Yi Hu, Guanzhen Yu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Avasimibe is a bioavailable acetyl-CoA acetyltransferase (ACAT) inhibitor and shows a good antitumor effect in various human solid tumors, but its therapeutic value in cholangiocarcinoma (CCA) and underlying mechanisms are largely unknown. In the stu
Externí odkaz:
https://doaj.org/article/f8041295a0cf4b93ae6c0de2e39bffd1
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background A-disintegrin and metalloproteinases (ADAMs) are members of a family of multidomain transmembrane and secreted proteins. Specific ADAMs are upregulated in human cancers and correlated with tumor progression and poor outcome, but r
Externí odkaz:
https://doaj.org/article/802378e0b0774f4c8139c5d8e7085d35
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77625 (2013)
Twist-related protein 1 (Twist1), also known as class A basic helix-loop-helix protein 38 (bHLHa38), has been implicated in cell lineage determination and differentiation. Previous studies demonstrate that Twist1 expression is up-regulated in gastric
Externí odkaz:
https://doaj.org/article/9440547831bc464db775b08fed367e0d
Publikováno v:
Proceedings of the 2022 6th International Conference on Electronic Information Technology and Computer Engineering.
Autor:
Haoran Bai, Xiaoqiang Gu, Dan Meng, Jinzu Yang, Jiahua Xu, Jianxin Qian, Ling Chen, Xin Li, Hongwei Li
Publikováno v:
OncoTargets and therapy
Background HER2-positive patients with advanced gastric cancer have a poor prognosis, and trastuzumab-resistant patients lack effective treatment. Case presentation We report a 72-year-old male with HER2-positive gastric cancer. The patient had metas